Regeneron Pharmaceuticals Inc
F:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
F:RGO
|
US |
|
A
|
Air China Ltd
SWB:AD2
|
CN |
|
Sumitomo Realty & Development Co Ltd
TSE:8830
|
JP |
|
Elbit Systems Ltd
NASDAQ:ESLT
|
IL |
|
Atul Ltd
BSE:500027
|
IN |
|
Anup Engineering Ltd
NSE:ANUP
|
IN |
|
Bushveld Minerals Ltd
LSE:BMN
|
ZA |
|
T
|
Teradyne Inc
F:TEY
|
US |
|
Piramal Enterprises Ltd
NSE:PEL
|
IN |
|
Frontier Lithium Inc
XTSX:FL
|
CA |
|
S
|
Svenska Cellulosa SCA AB
XMUN:SCA
|
SE |
|
B
|
Brainchip Holdings Ltd
OTC:BRCHF
|
AU |
|
R
|
Rai Way SpA
F:4RW
|
IT |
|
U
|
Ucore Rare Metals Inc
OTC:UURAF
|
CA |
|
Olectra Greentech Ltd
NSE:OLECTRA
|
IN |
|
M
|
MFE-MEDIAFOREUROPE NV
MIL:MFEB
|
IT |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 733.87 EUR with a low forecast of 554.45 EUR and a high forecast of 923.12 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
733.87
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 733.87 EUR with a low forecast of 554.45 EUR and a high forecast of 923.12 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
The compound annual growth rate for Operating Income over the next 8 years is 11%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 8 years is 8%.
